Matthew Guillod

Nov 14, 2024 | fcablog.sidley.com | Scott Stein |Jaime Jones |Matthew Guillod

On November 4, 2024, the Supreme Court heard oral argument in United States ex rel. Heath v. Wisconsin Bell. The question presented is whether reimbursement requests submitted to the private corporation administering the E-rate program are FCA “claims.” Under the statute’s definition of “claim,” the answer hinges on whether the Government “provides” the requested money. All funding for the program, established by Congress, comes from private contributions.

Jan 8, 2024 | lexology.com | Meenakshi Datta |Brenna Jenny |Donielle McCutcheon |Catherine Y. Starks |Kwaku Akowuah |Matthew Guillod

In late December 2023, the U.S. District Court for the District of Columbia issued an order that has important implications for pharmaceutical manufacturers that offer co-pay assistance for eligible patients.

Jun 27, 2023 | fcablog.sidley.com | Jaime Jones |Brenna Jenny |Matthew Guillod

On June 16, 2023, the Supreme Court issued its opinion in United States ex rel. Polansky v. Executive Health Resources, affirming that courts should grant DOJ motions to dismiss over relator objections “in all but the most exceptional cases.”  Prior coverage of this case is here and here.

Jun 12, 2023 | law360.com | Jaime L.M. Jones |Brenna Jenny |Matthew Guillod

By Jaime Jones, Brenna Jenny and Matthew Guillod (June 12, 2023, 4:32 PM EDT) -- Last month, the U.S. Department of Health and Human Services Office of Inspector General released the results of an audit on psychotherapy services provided during the first year of the COVID-19 pandemic, including those furnished through telehealth.[1]... Stay ahead of the curveIn the legal profession, information is the key to success.

Apr 3, 2023 | lexology.com | Meenakshi Datta |Brenna Jenny |Matthew Guillod

In the Inflation Reduction Act of 2022 (“IRA”), Congress made some of the most significant changes to the Medicare program since Congress first passed a prescription drug benefit in 2003. Successfully implementing these recent changes will require the Centers for Medicare & Medicaid Services (“CMS” or “the agency”) to understand and balance competing stakeholder concerns.  Federal agencies often do so by engaging in rigorous notice-and-comment processes.